Literature DB >> 24120602

Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus.

Takeshi Sugimoto1, Makoto Hashimoto1, Ikuyo Hayakawa1, Osamu Tokuno1, Tomoko Ogino1, Mariko Okuno1, Nobuhide Hayashi2, Seiji Kawano2, Daisuke Sugiyama3, Hironobu Minami1.   

Abstract

BACKGROUND: The aim of this study was to confirm the change in haemoglobin A1c consequent to pre-operative donation of autologous blood for elective surgery in patients with diabetes mellitus.
MATERIAL AND METHODS: For enrolment in this prospective study, patients had to be scheduled for multiple autologous blood donations at different times and have a haemoglobin A1c level more than 5.8% at the first donation. The values of four factors, haemoglobin, haemoglobin A1c, glycated albumin, and glycated albumin/haemoglobin A1c ratio were determined. Changes in the values of these four factors between before and after the blood donations were calculated.
RESULTS: In all 24 patients studied, haemoglobin and haemoglobin A1c decreased as a result of the autologous blood donations. The group with a reduced glycated albumin/haemoglobin A1c ratio had short intervals between blood donations. Correlations were observed between donation interval and change in haemoglobin A1c (r=-0.63, P=0.003), and between donation interval and change in the glycated albumin/haemoglobin A1c ratio (r=0.489, P=0.045). DISCUSSION: Haemoglobin A1c levels are likely to be underestimated after autologous blood donation by patients with diabetes mellitus, so glycated albumin may be a better indicator of these patients' glycaemic control.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24120602      PMCID: PMC3934276          DOI: 10.2450/2013.0271-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  10 in total

1.  Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia.

Authors:  Masafumi Koga; Kunihiko Hashimoto; Jun Murai; Hiroshi Saito; Mikio Mukai; Kazuhiro Ikegame; Hiroyasu Ogawa; Soji Kasayama
Journal:  Clin Chim Acta       Date:  2010-10-18       Impact factor: 3.786

Review 2.  Clinical impact of glycated albumin as another glycemic control marker.

Authors:  Masafumi Koga; Soji Kasayama
Journal:  Endocr J       Date:  2010-08-17       Impact factor: 2.349

3.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

4.  Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis.

Authors:  Nobuhiro Aizawa; Hirayuki Enomoto; Hiroyasu Imanishi; Masaki Saito; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Yoshiyuki Sakai; Tomoyuki Takashima; Takashi Iwai; Ei-Ichiro Moriwaki; Soji Shimomura; Hiroko Iijima; Hideji Nakamura; Shuhei Nishiguchi
Journal:  World J Hepatol       Date:  2012-01-27

Review 5.  The measurement and importance of red cell survival.

Authors:  Robert S Franco
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

Review 6.  Pre-operative autologous blood donation: clinical parameters and efficacy.

Authors:  Günter Singbartl
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

Review 7.  Autologous blood procurement in the surgical setting: lessons learned in the last 10 years.

Authors:  L T Goodnough; T G Monk; M E Brecher
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

8.  The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo.

Authors:  H F Bunn; D N Haney; S Kamin; K H Gabbay; P M Gallop
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

9.  Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients.

Authors:  R Dolhofer; O H Wieland
Journal:  FEBS Lett       Date:  1979-07-15       Impact factor: 4.124

Review 10.  Safety of blood donation from individuals with treated hypertension or non-insulin dependent type 2 diabetes - a systematic review.

Authors:  D Stainsby; S Brunskill; C E Chapman; C Dorée; S Stanworth
Journal:  Vox Sang       Date:  2009-10-29       Impact factor: 2.144

  10 in total
  3 in total

1.  Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports.

Authors:  Nicola Lamberti; Alessia Finotti; Jessica Gasparello; Ilaria Lampronti; Christel Zambon; Lucia Carmela Cosenza; Enrica Fabbri; Nicoletta Bianchi; Francesca Dalla Corte; Maurizio Govoni; Roberto Reverberi; Roberto Gambari; Fabio Manfredini
Journal:  Intern Emerg Med       Date:  2018-03-23       Impact factor: 3.397

Review 2.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

3.  Autologous blood transfusion augments impaired wound healing in diabetic mice by enhancing lncRNA H19 expression via the HIF-1α signaling pathway.

Authors:  Jian-Rong Guo; Lei Yin; Yong-Quan Chen; Xiao-Ju Jin; Xun Zhou; Na-Na Zhu; Xiao-Qian Liu; Han-Wei Wei; Li-Shuang Duan
Journal:  Cell Commun Signal       Date:  2018-11-20       Impact factor: 5.712

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.